lycera.comHealthcareFounded: 1900Funding to Date: $106.06MM
Lycera is a biopharmaceutical company that seeks to uncover new small molecule therapies for the treatment of autoimmune diseases and cancer.
For more details on financing and valuation for Lycera, register or login.
View Enterprise Value for Lycera.
To read this article and more news on Lycera, register or login.